Project Number 3R01CA225830-03S1 Agency/Funding Organization NCI Funding Year 2020 View Full Project Details for Determining the effects of bone morphogenetic protein receptor 2 (BMPR2) inhibition on neural stem cell neurogenesis and regulation of energy homeostasis in Alzheimer?s disease and cancer Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies d. Prions Researcher and Organization Principal Investigator LANGENFELD, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name LANGENFELD Awardee Organization RBHS -CANCER INSTITUTE OF NEW JERSEY Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $389,236 Funding Organization Agency/Funding Organization NCI Funding Organization Country United States
